Asaf Levi
About Asaf Levi
Asaf Levi is a director and chairman at NRGene Ltd., with extensive experience in board advisory roles across various companies. He is also the founder and CEO of Flow Group, specializing in venture capital investment.
Current Role at Ayyeka Technologies
Asaf Levi has been serving as a Director at Ayyeka Technologies since 2020. In addition to this role, he has been a Board Observer and Adviser to the Board of Directors since 2016. His involvement spans over eight years, during which he has contributed to the strategic direction and governance of the company.
Experience at NRGene Ltd.
Levi has held the position of Chairman of the Board at NRGene Ltd. since 2019. He also serves as a Director at the same company, a role he has maintained since 2016. His leadership at NRGene reflects his extensive experience in guiding organizations in the biotechnology sector.
Advisory Roles in Multiple Companies
Levi serves as a Board Observer and Adviser to the Board of Directors for several companies, including ViruCure Therapeutics and Wisesight Technologies Ltd., both since 2017. His advisory roles focus on providing expertise in business strategy and governance, supporting the growth and development of these organizations.
Educational Background
Levi's educational background includes a Bachelor of Business Administration (BBA) in Economics and Business Management from The Open University of Israel, completed from 2000 to 2005. He also studied Investment & Pension advising and participated in a Directors workshop at the same institution. Additionally, he studied Java Development at John Bryce from 2005 to 2006.
Founder and CEO of Flow Group
Asaf Levi is the Founder and CEO of Flow Group, which manages two venture capital investment funds. His role involves overseeing investment strategies and providing support to early-stage companies, reflecting his commitment to fostering innovation and entrepreneurship.